Clinical trials are time consuming, expensive, and often burdensome on patients. Clinical
trials can fail for many reasons. This survey reviews many of these reasons and offers …

Financial toxicity is the adverse impact of a cancer diagnosis on a patient's financial well‐
being resulting from direct or indirect costs. Potential consequences of financial toxicity …

Objective To determine the extent of financial toxicity (FT) among cancer survivors, identify
the determinants and how FT is measured. Methods A systematic review was performed in …

Purpose To estimate the prevalence of financial hardship associated with cancer in the
United States and identify characteristics of cancer survivors associated with financial …

BACKGROUND Considering patients' experience is essential for optimal decision‐making.
However, despite increasing recognition of the impact of costs on oncology care, there is no …

Clinical trials are imperative for testing novel cancer therapies, advancing the science of
cancer care, and determining the best treatment strategies to enhance outcomes for patients …

Molecular and immune therapies have revolutionized cancer treatment and improved
patient outcomes and survival. However, the pricing of these drugs has become an issue as …

Purpose: Because of the escalating cost of cancer care coupled with high insurance
deductibles, premiums, and uninsured populations, patients with cancer are affected by …

Background Financial toxicity is increasingly recognised as adversely affecting the quality of
life and medication adherence in patients with cancer in the USA. Patients with multiple …

Patients with cancer who live at home often require help with activities of daily living, basic
medical care (eg, injections), social needs, and patient advocacy. Most of that support …